LUK INSIGHT
PDRN Now Sells
by the Numbers
22 subjects, 4 weeks, 10 endpoints — inside one PDRN ampoule's human application test
Source : KSRC Korean Skin Research Center, Human Application Test Final Report (Apr 2025)
Few ingredients have become a global beauty language as fast as PDRN. Derived from salmon DNA, it began life as a regenerative ingredient in dermatology clinics and, within a few years, has rewritten the home-care category — ampoules, serums, creams. In buyer meetings today, "Do you have a PDRN product?" is practically a greeting.
But as the market heats up, the follow-up question is changing: "So — do you have the data?" In this issue, LUK Insight reads the PDRN market through the final report of a human application test on a PDRN ampoule developed by a Korean bio company — a market where proof itself has become the competitive edge.
From the Clinic to the Vanity
PDRN (polydeoxyribonucleotide) built its career in regenerative medicine. Popularized through skin-booster treatments, it crossed into cosmetics and became social media shorthand — the "salmon ampoule." For a home-care market hungry for clinic-grade stories without the clinic, PDRN was the perfect ingredient.
Then came the crowd. As entry barriers fell, products claiming "with PDRN" flooded in — at wildly different concentrations and quality levels, all competing under the same name. The ingredient name alone no longer differentiates. That is exactly where the PDRN category stands today.
Hot Ingredients Need Cold Data
The second half of every ingredient boom plays out the same way. Retailers ask for efficacy evidence at listing review. Import regulators and ad-screening bodies demand substantiation for every claim. And consumers, fluent in reviews and ingredient lists, care less about who said it first — and more about who proved it.
The common language that answers all of them is the human application test: efficacy verified at a certified clinical institution, under IRB approval and GCP standards, with statistical significance (p<0.05). One document changes what your product page can say, how far your ads can go, and the temperature of your buyer negotiations.
One Ampoule, Ten Numbers
A recent case makes the point. A PDRN ampoule (formulated with sodium DNA) developed by a Korean bio company completed its human application test at KSRC Korean Skin Research Center. The design:
Subjects 22 adults, ages 19–59 (mean 49.4)
Design Single-use, 2-week and 4-week application, including untreated-control comparison
Standards Conducted under GCP and MFDS regulations, with IRB approval
Endpoints 10 measures — deep hydration, radiance, soothing, tone, texture, translucency, elasticity, lifting, density, pores — plus adverse reactions
The result: statistically significant improvement (p<0.05) across all ten endpoints.
+32.45%
Skin density (2 wks)
26.35%
Lifting improvement (2 wks)
+11.30%
Elasticity (2 wks)
+8.53%
Skin translucency (2 wks)
+8.26%
Radiance (2 wks)
−7.09%
Texture roughness (2 wks)
+3.75%
Deep hydration (2 wks)
−6.67%
Pore volume (4 wks)
Triple skin tone (L*·a*·b*) also improved significantly at 2 weeks — 1.06%, 3.70%, and 1.84% respectively. All figures are change rates vs. baseline, p<0.05.
The standout number — soothing after a single use
After infrared (heat) stress, a single application lowered skin temperature by 11.71% — versus 2.23% on the untreated control site. That's roughly a 5× difference, and it turns "you feel it instantly" from a slogan into a substantiated claim.
Zero adverse reactions were observed throughout the study, and the user survey returned 100% positive responses on every item — after both single use and two weeks of use.
The Next Frontier: DNA × Cellular Energy
The ampoule's ingredient list carries one more signal. Alongside sodium DNA sit cellular-energy actives: NMN (nicotinamide mononucleotide), NAD (nicotinamide adenine dinucleotide), and ATP (disodium adenosine triphosphate).
Where first-generation products cast PDRN as a solo hero, newer formulations pair the "regeneration story" with an "energy story" — borrowing NMN and NAD, keywords already proven in the wellness market, into skincare language. For anyone planning next season's PDRN line, this combination is the direction to watch.
LUK'S INSIGHT
1. PDRN has moved from a concentration race to a proof race
As more products share the same ingredient name, clinical data decides listing reviews and buyer negotiations. Data isn't a cost — it's what protects your margin.
2. Choosing test endpoints is designing your claims
Testing 10 endpoints — hydration, soothing, elasticity, pores — as in this case dramatically widens what a product page is allowed to say. Work backward from the claims you want to sell.
3. Pair instant results with cumulative results
Single-use soothing (felt immediately) plus 2–4 week structural improvement (built over time) in one study targets first reviews and repurchases at once.
Build a PDRN product armed with clinical data
LUK Corp. connects concept planning, formulation design, human application test design, and export documentation in one flow.
If a PDRN line is on your roadmap, let's start with the data strategy.
ceo@luk.co.kr · Instagram @lukcos_2015
Source : KSRC Korean Skin Research Center, Human Application Test Final Report on a PDRN ampoule commissioned by a Korean bio company (Apr 2025) — 22 subjects, 10 endpoints, p<0.05
#LUKInsight #DeliveryFirstBeauty #Beauty #PDRN